93 related articles for article (PubMed ID: 15191374)
1. A case of plasmacytic hyperplasia arising in a kidney allograft salvaged with immunosuppression reduction alone.
Harada H; Miura M; Shimoda N; Seki T; Togashi M; Ogawa Y; Takada A; Tahara M; Sato H; Hirano T
Clin Transplant; 2004; 18 Suppl 11():50-3. PubMed ID: 15191374
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
3. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder.
Gautam A; Morrissey PE; Brem AS; Fischer SA; Gohh RY; Yango AF; Monaco AP
Pediatr Transplant; 2006 Aug; 10(5):613-6. PubMed ID: 16856999
[TBL] [Abstract][Full Text] [Related]
4. Rapidly developing T-cell posttransplantation lymphoproliferative disorder.
Kim JY; Kim CW; Ahn C; Bang YJ; Lee HS
Am J Kidney Dis; 1999 Jul; 34(1):e3. PubMed ID: 10401041
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
[TBL] [Abstract][Full Text] [Related]
7. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
[TBL] [Abstract][Full Text] [Related]
8. Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.
Pan K; Franke AJ; Skelton WP; Bishnoi R; Shah C; Dang NH; Alquadan K
Leuk Lymphoma; 2021 May; 62(5):1123-1128. PubMed ID: 33327817
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
Taylor AL; Bowles KM; Callaghan CJ; Wimperis JZ; Grant JW; Marcus RE; Bradley JA
Transplantation; 2006 Aug; 82(3):375-81. PubMed ID: 16906036
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
Taylor AL; Marcus R; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.
Johnson J; Kerecuk L; Harrison M; Taylor JO; Odell E
Pediatr Transplant; 2007 May; 11(3):340-4. PubMed ID: 17430495
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant lymphoproliferative disorder in the wall of a lymphocele: a case report.
Basic-Jukic N; Kes P; Coric M; Kastelan Z; Pasini J; Bubic-Filipi L
Transplant Proc; 2009 Jun; 41(5):1966-8. PubMed ID: 19545769
[TBL] [Abstract][Full Text] [Related]
15. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
16. Steroid-free immunosuppression after renal transplantation-long-term experience from a single centre.
El-Faramawi M; Rohr N; Jespersen B
Nephrol Dial Transplant; 2006 Jul; 21(7):1966-73. PubMed ID: 16574678
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
Beynet DP; Wee SA; Horwitz SS; Kohler S; Horning S; Hoppe R; Kim YH
Arch Dermatol; 2004 Sep; 140(9):1140-6. PubMed ID: 15381556
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
Quintini C; Kato T; Gaynor JJ; Ueno T; Selvaggi G; Gordon P; McLaughlin G; Tompson J; Ruiz P; Tzakis A
Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
[TBL] [Abstract][Full Text] [Related]
20. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
